• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体疾病中氧化磷酸化和脂肪酸β-氧化的联合缺陷

Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease.

作者信息

Nsiah-Sefaa Abena, McKenzie Matthew

机构信息

Centre for Genetic Diseases, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia The Department of Molecular and Translational Science, Monash University, Clayton, Victoria 3168, Australia.

Centre for Genetic Diseases, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia The Department of Molecular and Translational Science, Monash University, Clayton, Victoria 3168, Australia

出版信息

Biosci Rep. 2016 Feb 2;36(2):e00313. doi: 10.1042/BSR20150295.

DOI:10.1042/BSR20150295
PMID:26839416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4793296/
Abstract

Mitochondria provide the main source of energy to eukaryotic cells, oxidizing fats and sugars to generate ATP. Mitochondrial fatty acid β-oxidation (FAO) and oxidative phosphorylation (OXPHOS) are two metabolic pathways which are central to this process. Defects in these pathways can result in diseases of the brain, skeletal muscle, heart and liver, affecting approximately 1 in 5000 live births. There are no effective therapies for these disorders, with quality of life severely reduced for most patients. The pathology underlying many aspects of these diseases is not well understood; for example, it is not clear why some patients with primary FAO deficiencies exhibit secondary OXPHOS defects. However, recent findings suggest that physical interactions exist between FAO and OXPHOS proteins, and that these interactions are critical for both FAO and OXPHOS function. Here, we review our current understanding of the interactions between FAO and OXPHOS proteins and how defects in these two metabolic pathways contribute to mitochondrial disease pathogenesis.

摘要

线粒体为真核细胞提供主要能量来源,通过氧化脂肪和糖类来生成三磷酸腺苷(ATP)。线粒体脂肪酸β-氧化(FAO)和氧化磷酸化(OXPHOS)是这一过程的两个核心代谢途径。这些途径的缺陷可导致脑、骨骼肌、心脏和肝脏疾病,约每5000例活产中就有1例受影响。目前尚无针对这些疾病的有效治疗方法,大多数患者的生活质量严重下降。这些疾病许多方面的病理机制尚未完全明确;例如,尚不清楚为何一些原发性FAO缺陷患者会出现继发性OXPHOS缺陷。然而,最近的研究结果表明,FAO和OXPHOS蛋白之间存在物理相互作用,且这些相互作用对FAO和OXPHOS功能均至关重要。在此,我们综述了目前对FAO和OXPHOS蛋白之间相互作用的理解,以及这两个代谢途径中的缺陷如何导致线粒体疾病的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f334/4793296/1150ec242d2a/bsr036e313fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f334/4793296/b20eb3b37789/bsr036e313fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f334/4793296/1150ec242d2a/bsr036e313fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f334/4793296/b20eb3b37789/bsr036e313fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f334/4793296/1150ec242d2a/bsr036e313fig2.jpg

相似文献

1
Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease.线粒体疾病中氧化磷酸化和脂肪酸β-氧化的联合缺陷
Biosci Rep. 2016 Feb 2;36(2):e00313. doi: 10.1042/BSR20150295.
2
Understanding the role of OXPHOS dysfunction in the pathogenesis of ECHS1 deficiency.理解 OXPHOS 功能障碍在 ECHS1 缺乏症发病机制中的作用。
FEBS Lett. 2020 Feb;594(4):590-610. doi: 10.1002/1873-3468.13735. Epub 2020 Jan 29.
3
Loss of the Mitochondrial Fatty Acid β-Oxidation Protein Medium-Chain Acyl-Coenzyme A Dehydrogenase Disrupts Oxidative Phosphorylation Protein Complex Stability and Function.线粒体脂肪酸β氧化蛋白中链酰基辅酶 A 脱氢酶缺失破坏氧化磷酸化蛋白复合物的稳定性和功能。
Sci Rep. 2018 Jan 9;8(1):153. doi: 10.1038/s41598-017-18530-4.
4
Evidence for physical association of mitochondrial fatty acid oxidation and oxidative phosphorylation complexes.线粒体脂肪酸氧化与氧化磷酸化复合物物理关联的证据。
J Biol Chem. 2010 Sep 24;285(39):29834-41. doi: 10.1074/jbc.M110.139493. Epub 2010 Jul 27.
5
Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders.线粒体医学:从代谢角度看氧化磷酸化障碍的病理学
Cell Metab. 2006 Jan;3(1):9-13. doi: 10.1016/j.cmet.2005.12.001.
6
Association between glaucoma susceptibility with combined defects in mitochondrial oxidative phosphorylation and fatty acid beta oxidation.青光眼易感性与线粒体氧化磷酸化和脂肪酸β氧化联合缺陷之间的关联。
Mol Aspects Med. 2024 Apr;96:101238. doi: 10.1016/j.mam.2023.101238. Epub 2024 Jan 11.
7
Mitochondria: mitochondrial OXPHOS (dys) function ex vivo--the use of primary fibroblasts.线粒体:离体线粒体氧化磷酸化(功能异常)——原代成纤维细胞的应用
Int J Biochem Cell Biol. 2014 Mar;48:60-5. doi: 10.1016/j.biocel.2013.12.010. Epub 2014 Jan 7.
8
In vitro treatment of HepG2 cells with saturated fatty acids reproduces mitochondrial dysfunction found in nonalcoholic steatohepatitis.用饱和脂肪酸对HepG2细胞进行体外处理,可重现非酒精性脂肪性肝炎中发现的线粒体功能障碍。
Dis Model Mech. 2015 Feb;8(2):183-91. doi: 10.1242/dmm.018234. Epub 2014 Dec 24.
9
Loss of mitochondrial fatty acid β-oxidation protein short-chain Enoyl-CoA hydratase disrupts oxidative phosphorylation protein complex stability and function.线粒体脂肪酸β-氧化蛋白短链烯酰基辅酶 A 水合酶缺失破坏氧化磷酸化蛋白复合物的稳定性和功能。
FEBS J. 2023 Jan;290(1):225-246. doi: 10.1111/febs.16595. Epub 2022 Aug 24.
10
Acylcarnitine profiles in fibroblasts from patients with respiratory chain defects can resemble those from patients with mitochondrial fatty acid beta-oxidation disorders.呼吸链缺陷患者成纤维细胞中的酰基肉碱谱可能类似于线粒体脂肪酸β氧化障碍患者的酰基肉碱谱。
Metabolism. 2002 Mar;51(3):366-71. doi: 10.1053/meta.2002.30521.

引用本文的文献

1
Investigating the Therapeutic Potential of miRNA-137-3p/383-5p/PGC-1α Signalling Nexus Against Cardiac Hypertrophy.研究miRNA-137-3p/383-5p/PGC-1α信号轴抗心肌肥厚的治疗潜力
J Cardiovasc Transl Res. 2025 Jun 23. doi: 10.1007/s12265-025-10636-9.
2
Effects of atmospherically relevant PM on skeletal muscle mitochondria: a review of damage mechanisms and potential of exercise interventions.大气相关颗粒物对骨骼肌线粒体的影响:损伤机制及运动干预潜力综述
Front Public Health. 2025 Jun 4;13:1615363. doi: 10.3389/fpubh.2025.1615363. eCollection 2025.
3
TNFα activation of the PLEKHA5-FCRLA axis disturbs lipid metabolism, leading to the progression of cutaneous malignant melanoma.

本文引用的文献

1
The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders.线粒体脂肪酸β-氧化的生物化学与生理学及其遗传疾病
Annu Rev Physiol. 2016;78:23-44. doi: 10.1146/annurev-physiol-021115-105045. Epub 2015 Oct 14.
2
Clinical, biochemical and metabolic characterisation of a mild form of human short-chain enoyl-CoA hydratase deficiency: significance of increased N-acetyl-S-(2-carboxypropyl)cysteine excretion.一种轻度人类短链烯酰辅酶A水合酶缺乏症的临床、生化及代谢特征:N-乙酰-S-(2-羧丙基)半胱氨酸排泄增加的意义
J Med Genet. 2015 Oct;52(10):691-8. doi: 10.1136/jmedgenet-2015-103231. Epub 2015 Aug 6.
3
肿瘤坏死因子α(TNFα)激活PLEKHA5-FCRLA轴会扰乱脂质代谢,导致皮肤恶性黑色素瘤进展。
Lipids Health Dis. 2025 Jun 3;24(1):198. doi: 10.1186/s12944-025-02597-4.
4
Hormonal Crossroads in Inborn Errors of the Metabolism Impact of Puberty and Dietary Interventions on Metabolic Health.代谢先天性缺陷中的激素交叉点:青春期和饮食干预对代谢健康的影响
Metabolites. 2025 Mar 28;15(4):235. doi: 10.3390/metabo15040235.
5
Hidden β-γ Dehydrogenation Products in Long-Chain Fatty Acid Oxidation Unveiled by NMR: Implications on Lipid Metabolism.核磁共振揭示长链脂肪酸氧化中的隐藏β-γ脱氢产物:对脂质代谢的影响
ACS Bio Med Chem Au. 2025 Mar 15;5(2):262-267. doi: 10.1021/acsbiomedchemau.4c00140. eCollection 2025 Apr 16.
6
Mitochondria associated membranes in dilated cardiomyopathy: connecting pathogenesis and cellular dysfunction.扩张型心肌病中的线粒体相关膜:连接发病机制与细胞功能障碍
Front Cardiovasc Med. 2025 Mar 17;12:1571998. doi: 10.3389/fcvm.2025.1571998. eCollection 2025.
7
A novel polyribonucleotide nucleotidyltransferase 1 () gene variant potentially associated with combined oxidative phosphorylation deficiency 13: case report and literature review.一种可能与联合氧化磷酸化缺陷13相关的新型多核糖核苷酸核苷酸转移酶1()基因变异:病例报告及文献综述
Transl Pediatr. 2025 Feb 28;14(2):338-349. doi: 10.21037/tp-24-419. Epub 2025 Feb 25.
8
Bioenergetic-related gene expression in the hippocampus predicts internalizing vs. externalizing behavior in an animal model of temperament.海马体中与生物能量相关的基因表达可预测气质动物模型中的内化行为与外化行为。
Front Mol Neurosci. 2025 Mar 4;18:1469467. doi: 10.3389/fnmol.2025.1469467. eCollection 2025.
9
Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma.鉴定DAP3作为肝细胞癌的候选预后标志物和潜在治疗靶点。
Front Immunol. 2025 Feb 20;16:1528853. doi: 10.3389/fimmu.2025.1528853. eCollection 2025.
10
Gut microbiome synthesizes important core metabolites to prevent cognitive decline and mitigate onset and progression of Alzheimer's disease.肠道微生物群合成重要的核心代谢物,以预防认知能力下降,并减轻阿尔茨海默病的发病和进展。
J Alzheimers Dis Rep. 2024 Dec 23;8(1):1705-1721. doi: 10.1177/25424823241309024. eCollection 2024.
Whole-exome sequencing identifies novel ECHS1 mutations in Leigh syndrome.
全外显子组测序鉴定 Leigh 综合征中的新型 ECHS1 突变。
Hum Genet. 2015 Sep;134(9):981-91. doi: 10.1007/s00439-015-1577-y. Epub 2015 Jun 23.
4
Clinical and biochemical characterization of four patients with mutations in ECHS1.4例ECHS1基因突变患者的临床和生化特征
Orphanet J Rare Dis. 2015 Jun 18;10:79. doi: 10.1186/s13023-015-0290-1.
5
A recessive homozygous p.Asp92Gly SDHD mutation causes prenatal cardiomyopathy and a severe mitochondrial complex II deficiency.隐性纯合子p.Asp92Gly SDHD突变导致产前心肌病和严重的线粒体复合物II缺乏。
Hum Genet. 2015 Aug;134(8):869-79. doi: 10.1007/s00439-015-1568-z. Epub 2015 May 26.
6
Deficiency of ECHS1 causes mitochondrial encephalopathy with cardiac involvement.ECHS1 缺乏导致伴有心脏受累的线粒体脑肌病。
Ann Clin Transl Neurol. 2015 May;2(5):492-509. doi: 10.1002/acn3.189. Epub 2015 Mar 13.
7
Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency.ACAD9的复合体I组装功能和脂肪酸氧化酶活性均对ACAD9缺乏症的疾病严重程度有影响。
Hum Mol Genet. 2015 Jun 1;24(11):3238-47. doi: 10.1093/hmg/ddv074. Epub 2015 Feb 26.
8
Mitochondrial disease heterogeneity: a prognostic challenge.线粒体疾病异质性:一项预后挑战。
Acta Myol. 2014 Oct;33(2):86-93.
9
ECHS1 mutations cause combined respiratory chain deficiency resulting in Leigh syndrome.ECHS1基因突变导致复合性呼吸链缺陷,进而引发 Leigh 综合征。
Hum Mutat. 2015 Feb;36(2):232-9. doi: 10.1002/humu.22730.
10
Familial very long chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant death: improved survival by prompt diagnosis.家族性极长链酰基辅酶A脱氢酶缺乏症作为新生儿猝死的原因:通过及时诊断提高生存率。
Am J Med Genet A. 2015 Jan;167A(1):211-4. doi: 10.1002/ajmg.a.36803. Epub 2014 Oct 22.